Crescent Biopharma, Inc.
CBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001253689
In the last 90 days, Crescent Biopharma, Inc. insiders filed 1 open-market purchase and 7 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $532.6M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Crescent Biopharma, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −5 vs. Q1 2025
- Shares held
- 10.8M
- −20.0M (−65.0%) vs. Q1 2025
- Total value
- $173.5M
- +$167.1M (+2,586.9%) vs. Q1 2025
- New holders
- 15
- 3 more added
- Sold out
- 20
- 12 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $532.6M |
| Q1 2026 | 63 | $476.6M |
| Q4 2025 | 58 | $285.9M |
| Q3 2025 | 41 | $134.6M |
| Q2 2025 | 30 | $173.5M |
| Q1 2025 | 35 | $6.46M |
| Q4 2024 | 41 | $7.56M |
| Q3 2024 | 36 | $3.00M |
| Q2 2024 | 35 | $7.20M |
| Q1 2024 | 69 | $110.5M |
| Q4 2023 | 58 | $82.8M |
| Q3 2023 | 49 | $52.1M |
| Q2 2023 | 55 | $61.9M |
| Q1 2023 | 54 | $46.6M |
| Q4 2022 | 48 | $83.3M |
| Q3 2022 | 35 | $14.3M |
| Q2 2022 | 37 | $15.8M |
| Q1 2022 | 44 | $31.2M |
| Q4 2021 | 47 | $42.7M |
| Q3 2021 | 48 | $64.9M |
| Q2 2021 | 58 | $72.5M |
| Q1 2021 | 78 | $110.4M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Crescent Biopharma, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 1,414,190 | $22.8M | 0.00% | +1,414,190 | New |
| Fairmount Funds Management LLC | 1,387,866 | $22.4M | 2.90% | +1,387,866 | New |
| VR Adviser, LLC | 1,387,864 | $22.4M | 1.68% | −1,612,136−53.7% | Reduced |
| BVF Inc | 1,387,863 | $22.4M | 0.80% | −8,156,399−85.5% | Reduced |
| Paradigm Biocapital Advisors LP | 642,721 | $10.4M | 0.44% | +642,721 | New |
| Logos Global Management LP | 553,686 | $8.94M | 1.19% | −4,846,314−89.7% | Reduced |
| Perceptive Advisors LLC | 453,686 | $7.32M | 0.27% | +453,686 | New |
| Commodore Capital LP | 453,686 | $7.32M | 0.52% | +453,686 | New |
| Deep Track Capital, LP | 453,686 | $7.32M | 0.24% | +453,686 | New |
| Boxer Capital Management, LLC | 453,686 | $7.32M | 3.69% | +453,686 | New |
| Frazier Life Sciences Management, L.P. | 453,685 | $7.32M | 0.29% | +453,685 | New |
| Soleus Capital Management, L.P. | 400,000 | $6.46M | 0.45% | +400,000 | New |
| Driehaus Capital Management LLC | 302,457 | $4.88M | 0.04% | +302,457 | New |
| Affinity Asset Advisors, LLC | 280,031 | $4.52M | 0.67% | +280,031 | New |
| Braidwell LP | 261,504 | $4.22M | 0.14% | +261,504 | New |
| Wellington Management Group LLP | 179,886 | $2.90M | 0.00% | −1,190,411−86.9% | Reduced |
| Adage Capital Partners GP, L.L.C. | 100,912 | $1.63M | 0.00% | −4,990,319−98.0% | Reduced |
| Blackstone Group Inc. | 75,614 | $1.22M | 0.01% | +75,614 | New |
| Tang Capital Management LLC | 50,152 | $809.5K | 0.04% | +50,152 | New |
| Jefferies Financial Group Inc. | 27,096 | $437.3K | 0.01% | −557,904−95.4% | Reduced |
| Morgan Stanley | 15,394 | $248.5K | 0.00% | +10,218+197.4% | Added |
| Bank of America Corp | 9,231 | $149.0K | 0.00% | +8,444+1,072.9% | Added |
| BlackRock, Inc. | 6,051 | $97.7K | 0.00% | −720,249−99.2% | Reduced |
| Barclays PLC | 286 | $4.62K | 0.00% | +210+276.3% | Added |
| UBS Group AG | 223 | $3.60K | 0.00% | −465,690−100.0% | Reduced |
| Group One Trading, L.P. | 162 | $2.62K | 0.00% | −24,263−99.3% | Reduced |
| SBI Securities Co., Ltd. | 68 | $1.10K | 0.00% | −6,874−99.0% | Reduced |
| Raymond James Financial Inc | 50 | $807 | 0.00% | +50 | New |
| BNP Paribas Arbitrage, SA | 4 | $65 | 0.00% | −477−99.2% | Reduced |
| Royal Bank of Canada | 20 | $0 | 0.00% | −1,980−99.0% | Reduced |
| Vanguard Group Inc | 0 | $0 | 0.00% | −2,670,208−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −571,726−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −382,573−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −356,768−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −179,265−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −116,985−100.0% | Sold out |
| Intellectus Partners, LLC | 0 | $0 | 0.00% | −45,965−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −38,363−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −36,326−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −30,580−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −16,936−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,740−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −13,854−100.0% | Sold out |
| Pine Valley Investments Ltd Liability Co | 0 | $0 | 0.00% | −12,520−100.0% | Sold out |
| 1 North Wealth Services LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Firethorn Wealth Partners, LLC | 0 | $0 | 0.00% | −11,700−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,032−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −9,353−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −1,309−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −126−100.0% | Sold out |